Event-free survival of infants and toddlers enrolled in the HR-NBL-1/SIOPEN trial is associated with the level of neuroblastoma mRNAs at diagnosis. [electronic resource]
Producer: 20190508Description: e27052 p. digitalISSN:- 1545-5017
- Area Under Curve
- Biomarkers, Tumor -- analysis
- Female
- Homeodomain Proteins -- analysis
- Humans
- Infant
- Infant, Newborn
- Kaplan-Meier Estimate
- Male
- Neuroblastoma -- metabolism
- Prognosis
- Progression-Free Survival
- Proportional Hazards Models
- RNA, Messenger -- analysis
- ROC Curve
- Sensitivity and Specificity
- Transcription Factors -- analysis
- Tyrosine 3-Monooxygenase -- analysis
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.